John Ratliff is stepping down as president and COO of Quintiles, a company that runs drug trials for pharmaceutical development, effective Dec. 31.
Ratliff joined the Research Triangle, N.C.-based company in 2004 as CFO and was named COO in 2006.
Quintiles President, COO Ratliff to step down
“Quintiles is known for its strong management team, and I'm confident that these executives will ensure a smooth transition for our customers, employees and the patients we ultimately serve,” Quintiles CEO Tom Pike said in a news release. “John helped to grow this team as Quintiles has grown. We wish him well in his future endeavors.”
The news of his departure came as the company reported its adjusted net income for the quarter ended Sept. 30 compared with 2012 was up 37%, to $71.9 million, on revenue of $932.7 million.
Letter
to the
Editor
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Sponsored Content